James and Esther King Biomedical Research Program   Report issue

Foundation Phase 1 Phase 2
Founded: Tallahassee FL United States (2018)

Organization Overview

First Clinical Trial
2018
NCT01625260
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

James and Esther King Biomedical Research Program